Register
Question 1
How is a "clinical trial" defined concerning medical devices?
Correct Answer:
A carefully controlled study to assess the safety and effectiveness of a medical device on subjects.
Explanation:
A clinical trial is defined as a carefully controlled study aimed at evaluating the safety and effectiveness of a medical device on human subjects. This process is crucial in the regulatory landscape, particularly for device approval, as it provides empirical evidence regarding how the device performs in real-world scenarios. Clinical trials are typically structured to gather data on various endpoints, such as patient outcomes, adverse effects, and comparison with existing standards of care. The results from these trials are essential for regulatory authorities, like the FDA, as they determine whether a medical device can be deemed safe for public use and whether it works as intended. The other options do not align with the definition of a clinical trial. A market study focusing on pricing strategies, for instance, does not involve the assessment of safety or effectiveness and instead analyzes market dynamics. An analysis of competitor devices in the market is more about understanding the competitive landscape rather than assessing a device’s performance. Similarly, surveys about design preferences focus on user experience and feedback and do not involve safety or effectiveness assessments.
Question 2
What are the three classes of medical devices as categorized by the FDA?
Correct Answer:
Class I, Class II, and Class III
Explanation:
The classification of medical devices by the FDA into Class I, Class II, and Class III is based on the level of control necessary to assure the safety and effectiveness of the device. Class I devices are those that pose the lowest risk and are subjected to the least regulatory control. They generally require simple controls to ensure their safety, such as good manufacturing practices. Examples include tongue depressors and band-aids. Class II devices have a moderate risk, and they require more regulatory controls than Class I devices to provide reasonable assurance of their safety and effectiveness. This often includes special labeling requirements, mandatory performance standards, and post-market surveillance. Examples include electric wheelchairs and infusion pumps. Class III devices are the most complex and pose the highest risk. They usually require premarket approval, which involves demonstrating the safety and effectiveness of the device through clinical trials. This category is for devices that support or sustain human life, are of substantial importance in preventing impairment of human health, or that present a potential unreasonable risk of illness or injury. An example of a Class III device is a pacemaker. The identification of the three classes is crucial for regulatory compliance and guides manufacturers on the necessary steps to take in order to bring a device to market.
Question 3
If a patient was hospitalized with acute sepsis after treatment with a device, how soon must the manufacturer report the event to the FDA?
Correct Answer:
30 calendar days
Explanation:
The requirement for manufacturers to report adverse events related to medical devices is dictated by FDA regulations. In the case of a serious adverse event, such as a patient being hospitalized with acute sepsis after treatment with a device, the manufacturer is obligated to report the event within a specific timeframe. The correct answer highlights that the manufacturer must submit a report within 30 calendar days of becoming aware of the adverse event. This aligns with the FDA's guidelines for the reporting of serious adverse events, ensuring that potential risks associated with medical devices are communicated promptly to the regulatory body. This timeframe allows the FDA to monitor the safety of devices, investigate potential links between devices and adverse events, and take necessary actions to protect public health. In contrast, the other options suggest shorter or longer reporting periods that do not meet the FDA's requirements for serious adverse events. For instance, the 5-day reporting timeframe is applicable to events that are deemed "immediate," but not to cases like acute sepsis that require a 30-day report. The quarterly or annual report options are also incorrect, as they do not specify the urgency of reporting immediate safety concerns regarding serious adverse events following device use. Thus, the 30-day guideline is essential for maintaining timely oversight of device safety.
Question 4
In a Non-Significant Risk device clinical trial, which of the following is NOT required before starting the trial?
Correct Answer:
Submission of the trial protocol to FDA for approval
Explanation:
In a Non-Significant Risk (NSR) device clinical trial, the submission of the trial protocol to the FDA for approval is not a requirement before starting the trial. This is due to the nature of NSR studies, which are considered to pose a lesser risk to participants compared to Significant Risk studies. Informed consent from trial participants is essential in all clinical trials to ensure participants are fully aware of the risks and benefits associated with their participation. Additionally, approval from an Institutional Review Board (IRB) is required to ensure that the study meets ethical standards and that participants are adequately protected. Financial disclosure by investigators is also mandatory to promote transparency and mitigate conflicts of interest, ensuring the integrity of the study. Since NSR trials do not necessitate prior FDA approval of the protocol, this step can be omitted for such studies, leading to the conclusion that it is the only option not required before initiating the trial.
Question 5
What is a major difference between an HDE and a PMA application?
Correct Answer:
Effectiveness requirements
Explanation:
The correct choice highlights a key distinction between Humanitarian Device Exemptions (HDE) and Premarket Approval (PMA) applications in terms of effectiveness requirements. HDEs are designed for devices intended to treat or diagnose conditions affecting fewer than 8,000 individuals per year in the United States. Because these devices are aimed at rare conditions or diseases, the FDA allows for a different approach regarding efficacy. Specifically, HDE does not require the applicant to demonstrate the same level of effectiveness that a PMA would necessitate. For PMA applications, the manufacturer must provide substantial evidence of safety and effectiveness for the device to receive FDA approval, which involves rigorous preclinical and clinical testing. In contrast, an HDE application only needs to demonstrate that the device is safe and that there is a reasonable assurance of its safety, along with showing that it provides a significant benefit, implying that it could help treat a condition that otherwise might not have sufficient treatment options. This relaxed standard reflects the unique nature of devices intended for rare diseases and supports innovation in areas where conventional approval trials might not be feasible. The other choices focus on technical aspects of the applications, such as content, labeling requirements, and supplemental applications, but the notable difference lies in how
Question 1
Exam overview

About this Exam

The Regulatory Affairs Certification (RAC) – Devices is a distinguished professional credential for individuals working within the medical device industry. Administered by the Regulatory Affairs Professionals Society (RAPS), it signifies that a practitioner possesses the knowledge and critical thinking skills essential for navigating the complex global regulatory landscape throughout a medical device’s entire lifecycle. This practice exam is specifically designed for regulatory affairs professionals, quality assurance specialists, and engineers with several years of experience, aiming to validate their expertise in pre-market submissions, post-market surveillance, and compliance with key regulations, such as those from the US FDA and the EU Medical Device Regulation (MDR).

More details

Additional Information

What the Course Entails and Exam Details

This practice material mirrors the comprehensive nature of the actual RAC Devices certification exam. It focuses on assessing your ability to apply regulatory knowledge to real-world scenarios rather than simple memorization. The content is meticulously updated annually to reflect the most current changes in regulations, guidelines, and industry standards.

The exam blueprint typically covers four main domains:

  • Strategic Planning: Including regulatory intelligence, product classification, and global regulatory strategy development.

  • Pre-Market Processes: Focusing on pre-submission interactions, clinical evidence requirements, and product registration pathways.

  • Post-Market Activities: Covering post-market surveillance, vigilance reporting, and life cycle management.

  • Interfacing: Addressing interactions with regulatory authorities, conformity assessment bodies, and internal stakeholders.


What to Expect in the Final Exam

You can expect a rigorous evaluation that tests both your depth of knowledge and your practical application. The actual RAC Devices exam is a computer-based, proctored test.

  • Format: The exam consists of approximately 100 to 120 multiple-choice questions.

  • Time Limit: Candidates are typically given 2 to 2.5 hours to complete the examination.

  • Question Types: The questions are categorized into three types: Recall (testing specific knowledge), Application (requiring you to relate knowledge to a specific scenario), and Analysis (case-based scenarios where you must evaluate various solutions).

  • Passing Score: RAPS uses a scaled scoring system (ranging from 0 to 99), and a scaled score of 75 or higher is required to pass.

  • Language: The exam is administered in English.


How to Study and Exam Centers

Preparation for the RAC Devices exam requires a dedicated and strategic approach. We highly recommend utilizing the official RAPS study resources, such as the Fundamentals of Medical Device Regulations, online university courses, and the detailed RAC Devices Candidate Guide, which includes the exam content outline and sample questions.

Study Strategies:

  • Analyze the Blueprint: Spend significant time understanding the domains and the percentage weight for each section to prioritize your study time effectively.

  • Practice with Mock Exams: Taking practice tests under timed, simulated conditions is one of the most effective methods to build stamina, improve time management, and identify knowledge gaps.

  • Master the Regulations: Develop a strong working knowledge of the specific regulations of target markets, such as 21 CFR Parts 800-898 for the USA, and EU MDR 2017/745 and IVDR 2017/746 for Europe.

Exam Centers:

You can take the RAC Devices exam year-round during specific testing windows. The exam is administered globally through a proctored, secure system provided by RAPS's testing partner, Pearson VUE. You can choose to take the exam at an authorized Pearson VUE professional testing center or, for added flexibility, through an online proctoring service in your own secure location.


Job Opportunities from the Course

Earning your RAC Devices designation can significantly enhance your career opportunities and earning potential. It provides external validation of your regulatory expertise, making you a highly desirable candidate for leadership roles.

Here are some specific job titles and career paths this certification unlocks:

  • Regulatory Affairs Specialist / Senior Specialist

  • Regulatory Affairs Manager

  • Director of Regulatory Affairs

  • Quality Assurance / Regulatory Compliance Manager

  • Medical Device Consultant

  • Regulatory Post-Market Surveillance Specialist

  • Clinical Affairs Regulatory Manager

  • Vigilance and Reporting Manager

Quiz information

Frequently Asked Questions

The complete question count is available after full access is unlocked.
No fixed duration is currently configured for this quiz.
Question explanations are included where they are available in the quiz content, helping you review the reasoning after answering.
Yes. You can retake the practice test again as you continue studying during your available access period.
After your access is confirmed, you can continue into the complete practice exam from this quiz flow.
Unless explicitly stated otherwise, this page provides independent practice material for study and exam preparation and is not the official examination itself.
Keep studying

Related Questions

2026 FFM Agent Broker Certification Practice Exam

0 min

3CX Academy Advanced Certification Practice Exam

0 min

3CX Academy Basic Certification Practice Exam

0 min

3CX Intermediate Certification Practice Exam

0 min

Ultimate Study Guide for the Argus Certification Practice Test

0 min

Arizona Caregiver Certification Practice Exam

0 min